Peter H Seeberger Selected Research

Oligosaccharides

7/2023	Synthesis of oligosaccharides to identify an immunologically active epitope against Candida auris infection.
12/2019	Synthetic Oligosaccharide-Based Vaccines Protect Mice from Clostridioides difficile Infections.
10/2017	A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
1/2017	Total synthesis of a Streptococcus pneumoniae serotype 12F CPS repeating unit hexasaccharide.
11/2016	A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection.
2/2012	Identification of mono- and disulfated N-acetyl-lactosaminyl Oligosaccharide structures as epitopes specifically recognized by humanized monoclonal antibody HMOCC-1 raised against ovarian cancer.
7/2011	Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface-associated anthrose-containing oligosaccharide.
9/2010	Anthrax spore detection by a luminex assay based on monoclonal antibodies that recognize anthrose-containing oligosaccharides.
1/2010	Solid phase synthesis of oligosaccharides.
9/2006	The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter H Seeberger Research Topics

Disease

27	Infections 01/2023 - 08/2006
25	Neoplasms (Cancer) 06/2023 - 02/2004
17	Malaria 01/2021 - 08/2002
8	Bacterial Infections (Bacterial Infection) 11/2021 - 05/2005
7	Inflammation (Inflammations) 10/2019 - 05/2005
6	Pneumococcal Infections 01/2022 - 11/2014
4	Breast Neoplasms (Breast Cancer) 06/2023 - 10/2016
4	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 11/2010
4	Communicable Diseases (Infectious Diseases) 06/2022 - 02/2014
4	Cerebral Malaria 01/2020 - 09/2013
3	Virus Diseases (Viral Diseases) 01/2023 - 05/2005
3	COVID-19 11/2021 - 01/2021
3	Parasitic Diseases (Parasitic Disease) 01/2020 - 08/2010
3	Leishmaniasis 01/2017 - 04/2006
3	Human Influenza (Influenza) 12/2016 - 11/2007
3	Pneumonia (Pneumonitis) 11/2016 - 11/2014
3	Anthrax 07/2011 - 10/2006
2	Neoplasm Metastasis (Metastasis) 06/2023 - 05/2005
2	Hypersensitivity (Allergy) 01/2022 - 01/2008
2	Parasitemia 03/2018 - 01/2016
2	Toxoplasmosis 01/2017 - 12/2014
2	Tuberculosis (Tuberculoses) 05/2015 - 05/2005
2	Colitis 01/2014 - 01/2013
1	Candida auris infection 07/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2023
1	Lymphoma (Lymphomas) 06/2023
1	Cross Infection (Nosocomial Infection) 10/2022
1	Ebola Hemorrhagic Fever 06/2022
1	Persistent Infection 01/2022

Drug/Important Bio-Agent (IBA)

26	Polysaccharides (Glycans)IBA 01/2023 - 08/2004
26	VaccinesIBA 11/2021 - 08/2002
21	CarbohydratesIBA 01/2023 - 08/2002
15	OligosaccharidesIBA 07/2023 - 02/2004
15	AntigensIBA 06/2023 - 02/2004
15	AntibodiesIBA 01/2022 - 10/2006
9	EpitopesIBA 07/2023 - 09/2006
9	Proteins (Proteins, Gene)FDA Link 06/2023 - 12/2009
8	GlycoconjugatesIBA 11/2021 - 05/2005
8	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2020 - 04/2008
6	Biomarkers (Surrogate Marker)IBA 06/2023 - 05/2015
6	Mannose (D-Mannose)IBA 11/2018 - 09/2002
5	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 11/2017
5	Conjugate VaccinesIBA 01/2021 - 11/2014
5	C-Type Lectins (C-Type Lectin)IBA 01/2019 - 01/2013
4	Monoclonal AntibodiesIBA 01/2023 - 09/2010
4	Carrier Proteins (Binding Protein)IBA 01/2022 - 11/2016
4	GlycolipidsIBA 01/2020 - 06/2010
4	CytokinesIBA 01/2017 - 10/2008
3	Peptides (Polypeptides)IBA 06/2022 - 01/2019
3	Mannose ReceptorIBA 11/2018 - 10/2016
3	Heparitin Sulfate (Heparan Sulfate)IBA 11/2017 - 02/2009
3	DisaccharidesIBA 01/2017 - 08/2004
3	Pattern Recognition ReceptorsIBA 01/2017 - 01/2013
2	RhamnoseIBA 06/2023 - 01/2018
2	Complement System Proteins (Complement)IBA 06/2023 - 01/2022
2	Cysteine (L-Cysteine)FDA Link 06/2023 - 09/2020
2	Cytotoxins (Cytolysins)IBA 06/2023 - 12/2019
2	ProteomeIBA 06/2022 - 01/2019
2	artemisinin (artemisinine)IBA 01/2022 - 02/2012
2	Globo-HIBA 01/2022 - 01/2010
2	Antimalarials (Antimalarial Agents)IBA 01/2022 - 01/2020
2	LipidsIBA 01/2022 - 11/2014
2	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2021 - 11/2018
2	Immunologic Factors (Immunomodulators)IBA 01/2019 - 01/2019
2	MucinsIBA 01/2019 - 01/2019
2	Malaria VaccinesIBA 01/2019 - 04/2005
2	Carbapenems (Carbapenem Antibiotics)IBA 12/2018 - 01/2018
2	IntegrinsIBA 11/2018 - 12/2009
2	Liposomes (Liposome)IBA 01/2018 - 11/2010
2	CyclodextrinsIBA 12/2016 - 10/2016
2	Virulence Factors (Pathogenicity Factors)IBA 05/2015 - 09/2006
2	ChemokinesIBA 06/2014 - 11/2007
2	Dextran SulfateIBA 01/2014 - 01/2013
2	4,6- dideoxy- 4- (3- hydroxy- 3- methylbutanamido)- 2- O- methylglucopyranoseIBA 07/2011 - 09/2010
2	Inositol (Myoinositol)IBA 06/2010 - 08/2004
2	Heparin (Liquaemin)FDA LinkGeneric 02/2009 - 03/2006
1	Single-Domain AntibodiesIBA 06/2023
1	Protein Disulfide-IsomerasesIBA 06/2023
1	Sulfhydryl Compounds (Thiols)IBA 06/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2023
1	Viral HemagglutininsIBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	TransferasesIBA 01/2022
1	Protein SIBA 01/2022
1	FucoseIBA 01/2022
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	AcyltransferasesIBA 01/2022
1	SolutionsIBA 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	PorphyrinsIBA 01/2022
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2022
1	ArtemisininsIBA 01/2022

Therapy/Procedure

4	Therapeutics 06/2023 - 01/2018
2	Lasers (Laser) 06/2022 - 01/2019
2	Photochemotherapy (Photodynamic Therapy) 01/2022 - 12/2016
1	Precision Medicine 06/2023
1	Radiotherapy 01/2023
1	Drug Therapy (Chemotherapy) 01/2022